Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ECD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PAIP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD63 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RUFY3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERP44 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DUSP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101060604 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
GPR75-ASB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSRNP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP1A1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C2orf42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NONO - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR4738 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KANSL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM103A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KAT5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
REV1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RIT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITSN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on